Benefits seen in phase 3 of Alzheimer's drug trial
Editor's Note Eisai, the Japanese drug maker, said on Tuesday September 27, that its experimental drug for Alzheimer’s disease helped slow cognitive decline to those experiencing early stages of the illness. In the phase 3 clinical trials, the drug, called lecanemab, slowed cognitive decline by 27% after 18 months, the…
Study: Robotic surgery safer than open surgery, less recovery time
Editor's Note In this clinical trial, scientists at University College London and the University of Sheffield found that robot-assisted surgery to remove and rebuild bladder cancer allowed patients to “recover much faster and spend considerably (20%) less time” in the hospital, SciTechDaily June 13 reports. Other findings included 52% less…
UW Medicine conducting national clinical trial on inflatable tubular stent
Editor's Note Cardiologists at the University of Washington School of Medicine (UW Medicine) in Seattle, Washington, are participating in a national clinical trial to test a device designed to control bleeding if a vessel near the heart is inadvertently perforated during a catheter-based procedure, Healthcare Purchasing News May 26 reported.…
Free Daily News
- Take the OR Manager Career/Salary Survey, help shape the future of perioperative leadership
- Virtual care, tech-enabled roles reshape nursing as leaders diverge on care redesign priorities
- As healthcare faces skyrocketing cyberattacks, surgeons are urged to lead frontline defense
- Study shows WHO surgical checklist boosts safety, but compliance gaps risk patient outcomes
- Kentucky Derby, SPD race: Leadership lessons energized SPD professionals at HSPA 2025
- Continuum-based protocol offers new strategy for preventing PONV after thyroidectomy
- Pembrolizumab sets new standard in advanced head and neck cancer surgery, trial shows
- Subarachnoid spinal anesthesia offers safe, effective option for high-risk obstetric patients
- Same-day discharge after catheter ablation gains backing from top cardiology societies
- Tenet, HCA post strong Q1 results, but caution looms over policy uncertainty, outpatient trends